Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules

International Journal of Pharmaceutics

Volumn 363, Issue 1-2, 2008, Pages 214-216

  Cattani, Vitória B ^a   Pohlmann, Adriana R ^a   Costa, Teresa Dalla ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Indomethacin; Indomethacin ethyl ester; Pharmacokinetics; Polymeric nanocapsules

Indexed keywords

INDOMETACIN; INDOMETHACIN ETHYL ESTER; NANOCAPSULE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG RELEASE; DRUG SCREENING; MALE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOTRANSFORMATION; DRUG COMPOUNDING; INDOMETHACIN; INJECTIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; NANOCAPSULES; PRODRUGS; RATS; RATS, WISTAR;

EID: 51649100976     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.07.008     Document Type: Article

References (9)

1. Ammoury N., Dubrasquet M., Fessi H., Devissaguet J.-Ph., Puisieux F., and Benita S. Indomethacin-loaded poly(D, L-lactide) nanocapsules: protection from gastrointestinal ulcerations and anti-inflammatory activity evaluation in rats. Clin. Mater. 13 (1993) 121-130
2. Bonina F., Trombetta D., Borzi A., De Pasquale A., and Saija A. 1-Ethylazacycloalkan-2-one indomethacin esters as new oral prodrugs: chemical stability, enzymatic hydrolysis, anti-inflammatory activity and gastrointestinal toxicity. Int. J. Pharm. 156 (1997) 245-250
3. Cruz L., Schaffazick S.R., Dalla Costa T., Soares L.U., Mezzalira G., Silveira N.P., Schapoval E.E.S., Pohlmann A.R., and Guterres S.S. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. J. Nanosci. Nanotechnol. 6 (2006) 3154-3162
4. Cruz L., Soares L.U., Dalla Costa T., Mezzalira G., Silveira N.P., Guterres S.S., and Pohlmann A.R. Diffusion and mathematical modeling of release profiles from nanocarriers. Int. J. Pharm. 313 (2006) 198-205
5. Hans M.L., and Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mat. Sci. 6 (2002) 319-327
6. Kalgutkar A.S., Marnett A.B., Crews B.C., Remmel R.P., and Marnett L.J. Ester and amide derivatives of the nonsteroidal antiinflamatory drug, indomethacin, as selective cyclooxigenase-2 inhibitors. J. Med. Chem. 43 (2000) 2860-2870
7. Palakurthi S., Vyas S.P., and Diwan P.V. Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. Int. J. Pharm. 290 (2005) 55-62
8. Raffin R.P., Obach E.S., Mezzalira G., Pohlmann A.R., and Guterres S.S. Nanocápsulas poliméricas secas contendo indometacina: estudo de formulação e de tolerência gastrintestinal em ratos. Acta Farm. Bonaer. 22 (2003) 163-172
9. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47 (1998) S78-87